CHARACTERIZATION OF STAT5B MUTATIONS AND TCRΒ REPERTOIRE IN CD4+ T LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 325371

AUTOPHAGY-RELATED GENETIC VARIANTS INFLUENCE THE RISK OF DEVELOPING CHRONIC LYMPHOCYTIC LEUKEMIA: A STUDY IN THE CONTEXT OF THE CRUCIAL CONSORTIUM

EHA Library, Ana Moñiz Díez, 325372

ANALYSIS OF GENOMIC COMPLEXITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING OPTICAL GENOME MAPPING

EHA Library, Anna Puiggros, 325376

THE IDO-KYN-AHR PATHWAY PROMOTES CHRONIC LYMPHOCYTIC LEUKEMIA CELLS SURVIVAL AND MITIGATES THE APOPTOTIC EFFECT OF ABT-199

EHA Library, Claudio Giacinto Atene, 325377

LNCRNA LANDSCAPE ANALYSIS IDENTIFIED LNCRNA LEF-AS1 AS AN ONCOGENE THAT UPREGULATES LEF1 AND PROMOTES SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 325378

SOMATIC HYPERMUTATION PROFILES IN STEREOTYPED IGHV4-34 RECEPTORS FROM SOUTH AMERICAN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Carmen Stanganelli, 325385

NGS APPROACH FOR IGHV REARRANGEMENT ANALYSIS IN CLL PATIENTS WITH OLIGOCLONAL DISEASE

EHA Library, Bella Biderman, 325386

OTHER MALIGNANCIES IN THE HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE, MULTICENTER COHORT STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL, IN HARMONY

EHA Library, Thomas Chatzikonstantinou, 325391

VENETOCLAX-OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION-BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

EHA Library, Othman Al-Sawaf, 325392

PIRTOBRUTINIB (LOXO-305), A NEXT GENERATION, HIGHLY SELECTIVE, NON-COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED CLL/SLL: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

EHA Library, Lindsey Roeker, 325393

MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB (IBR) TO VENETOCLAX (VEN) IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): THE IMPROVE STUDY

EHA Library, Lydia Scarfò, 325394

IBRUTINIB TREATMENT IN THE FIRST-LINE SETTING FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: UP TO 7 YEARS OF FOLLOW-UP IN THE RESONATE-2 STUDY

EHA Library, Paolo Ghia, 325396

TG-1701, A SELECTIVE BRUTON TYROSINE KINASE (BTK) INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH UBLITUXIMAB AND UMBRALISIB (U2) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND LYMPHOMA

EHA Library, Chan Y. Cheah, 325398

SYSTOLIC FUNCTION OF THE LEFT VENTRICULAR MYOCARDIAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IBRUTINIB.

EHA Library, Elena Emelina, 325401

PRELIMINARY RESULTS OF THE PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL MALIGNANCIES INTOLERANT TO IBRUTINIB AND/OR ACALABRUTINIB

EHA Library, Mazyar Shadman, 325402

A PHASE 1A/B DOSE ESCALATION STUDY OF THE MUTATION AGNOSTIC BTK/FLT3 INHIBITOR LUXEPTINIB (CG-806) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCIES

EHA Library, Rafael Bejar, 325403

REAL-WORLD EFFICACY AND SAFETY OF VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKAEMIA – FIRST DATA FROM THE VERONE STUDY, IN PATIENTS WITH VENETOCLAX MONOTHERAPY

EHA Library, Loic Ysebaert, 325406

MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB IN RICHTER TRANSFORMATION OF CLL: SAFETY INTERIM ANALYSIS

EHA Library, Anna Maria Frustaci, 325410

LEUKEMIA CUTIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE STUDY OF THE FRENCH INNOVATIVE LEUKEMIA ORGANIZATION (FILO)

EHA Library, Gregory Lazarian, 325412

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3-YEAR FOLLOW-UP

EHA Library, Ann Janssens, 325414

PROFILES OF NK CELL SUBSETS ARE ASSOCIATED WITH SUCCESSFUL TYROSINE KINASE INHIBITOR DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA AND CHANGE FOLLOWING INTERFERON TREATMENT

EHA Library, Hao Jiang, 325416

AGE-RELATED DNA DAMAGE RESPONSE (DDR) IN HEMATOPOIETIC STEM CELLS FROM CHRONIC MYELOID LEUKAEMIA PATIENTS WHO ATTEMPTED TKI DISCONTINUATION.

EHA Library, Chiara Manfroni, 325418

ASSESSMENT OF LEUKEMIC STEM CELL CD26+ IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE.

EHA Library, Raquel Bengió, 325419

EUTOS EXPERIENCE OF STANDARDISATION OF MOLECULAR MONITORING FOR CML (2016 – 2020). USE OF SECONDARY BCR-ABL1 REFERENCE MATERIALS FOR CONVERSION FACTOR VALIDATION AND ASSESSMENT OF MR4.5 DETECTION

EHA Library, Helen White, 325420

COMPREHENSIVE IMMUNOPROFILE OF NK CELLS FROM CML PATIENTS IN TFR REVEALS A POSSIBLE ROLE OF MEMORY-LIKE NK CELLS

EHA Library, Maria Belen Sanchez, 325423

TARGETING THE LEUKEMIC STEM CELL NICHE BY PI3K INHIBITORS IN CHRONIC MYELOID LEUKEMIA TO OVERCOME LEUKEMIC STEM CELL RESISTANCE

EHA Library, Yüksel Filik Schüppler, 325424

RARE MUTATIONS IN BCR-ABL THE KINASE DOMAIN IN CRONIC MYELOID LEUKEMIA PATIENTS.

EHA Library, Rocío Delamer, 325425

SECOND-LINE BOSUTINIB FOR PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA : FINAL 10-YEAR RESULTS OF A PHASE 1/2 STUDY

EHA Library, Carlo Gambacorti-Passerini, 325432

TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LOW-DOSE TKIS. A FEASIBLE OPTION ALSO IN THE REAL-LIFE SETTING?

EHA Library, Alessandra Iurlo, 325433

COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DISEASE OUTCOMES AND FIRST VACCINATION DATA IN RUSSIAN FEDERATION

EHA Library, Ekaterina Chelysheva, 325434

ASSOCIATION OF CREATINE KINASE ELEVATION WITH CLINICAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA

EHA Library, Aniket Bankar, 325435

EFFECT OF COMORBIDITIES ON PATIENT RESPONSES WITH FIRST-LINE DASATINIB VERSUS IMATINIB IN CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: EXPLORATORY POST HOC ANALYSIS OF DASISION

EHA Library, Breccia Massimo, 325437

HYDROXYUREA PRE-TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: MORE HARM THAN GOOD?

EHA Library, Camille C.B. Kockerols, 325438

TREATMENT ADHERENCE IN CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING TYROSINE KINASE INHIBITORS

EHA Library, S.M.Amine BENLAZAR, 325443

THE EFFECT OF BODY MASS INDEX ON EFFICACY AND SAFETY OF BOSUTINIB OR IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA

EHA Library, Tim Brümmendorf, 325444

EFFICACY AND SAFETY RESULTS FROM AN OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

EHA Library, Wilma Barcellini, 325445

RARE ANEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY PYRUVATE KINASE DEFICIENCY IN EUROPE

EHA Library, Maria Del Mar Mañú Pereira, 325446

FOSTAMATINIB FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): UPDATES FROM THE PHASE 2 AND PHASE 3 CLINICAL TRIALS

EHA Library, Dheepika Weerasinghe, 325447

INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 1-YEAR INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG-TERM FOLLOW-UP

EHA Library, Alexander Röth, 325449

CANCER RISK IN PATIENTS WITH WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA - A NATIONWIDE COHORT STUDY

EHA Library, Stinne Tranekaer, 325450

PHARMACOLOGIC INHIBITION OF PI3KΔ REDUCES AUTOANTIBODY FORMATION AND IS EFFICACIOUS IN A PRECLINICAL MODEL OF AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Paul Smith, 325453

MITAPIVAT AMELIORATES RED CELL FEATURES AND DECREASES ANEMIA IN BAND 4.2-/- MICE, A MODEL OF HEREDITARY SPHEROCYTOSIS

EHA Library, Alessandro Matte, 325455

WARM AUTOIMMUNE HEMOLYTIC ANEMIA IS ASSOCIATED WITH A REGULATORY T CELL DEFICIENCY AND A TH17 POLARIZATION

EHA Library, Marion Ciudad, 325457

MOLECULAR HETEROGENEITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN PORTUGAL

EHA Library, Licinio Manco, 325460

SYMPTOMATIC BONE MARROW RECONVERSION: A COMMON FEATURE IN HEREDITARY SPHEROCYTOSIS ?

EHA Library, Camille Pochard, 325461

SOLUBLE CTLA-4 IN CHILDREN WITH IMMUNE CYTOPENIAS: RELATION TO DISEASE ACTIVITY

EHA Library, Sara Makkeyah, 325462

IDENTIFICATION OF A WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) POPULATION USING PREDICTIVE ANALYTICS OF A KNOWN CLINICALLY PROFILED COHORT

EHA Library, Keith McCrae, 325463

AUTOIMMUNE HEMOLYTIC ANEMIA ASSOCIATED WITH LYMPHOID MALIGNANCIES: REPORT FROM A FRENCH PROSPECTIVE REGISTER.

EHA Library, Sylvain Audia, 325465

CLINICAL AND MOLECULAR CHARACTERISTICS OF IMERSLUND‐GRÄSBECK SYNDROME: FIRST REPORT OF A NOVEL FRAMESHIFT VARIANT IN EXON 11 OF AMN GENE

EHA Library, Mohamed Elshinawy, 325467

INFLAMMATION AND FATIGUE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): ANALYSIS FROM THE PHASE 3 CARDINAL STUDY

EHA Library, Ilene Weitz, 325469

THE GUT MICROBIOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tereza Faitova, 325373

EX VIVO DRUG SENSITIVITY IDENTIFIES COMBINATION TREATMENT WITH PI3K/BCL-2 INHIBITORS FOR MONOTHERAPY-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sigrid Skanland, 325374

THE IGLV3-21 LIGHT CHAIN ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Nadiia Bilous, 325375

DISCOVERY OF HBW-3-10: A POTENT, ORALLY ACTIVE, REVERSIBLE BRUTON’S TYROSINE KINASE (BTK) INHIBITOR WITH ANTITUMOR ACTIVITIES IN MICE

EHA Library, Chester Yuan, 325379

TARGETING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS WITH THE GLYCOGEN SYNTHASE KINASE-3 BETA (GSK-3Β)-SELECTIVE SMALL MOLECULE INHIBITOR, 9-ING-41

EHA Library, Estevao Carlos Silva Barcelos, 325380

INFLUENCE OF POLYMORPHISMS OF CODON 72 OF TP53 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Martin-Antonio Cabero-Becerra, 325381

CRISPR/CAS9 AND MRNA-BASED GENE EDITING AND EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Anna Kabanova, 325382

THE SIGNS OF NEGATIVE SELECTION IN IGHV FRAMEWORK REGIONS ARE ASSOCIATED WITH WORSE OVERALL SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Iryna Abramenko, 325383

GENE EXPRESSION MODEL TO IDENTIFY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH AN ULTRA-STABLE DISEASE. A CAMPUS CLL STUDY.

EHA Library, Ilaria Del Giudice, 325384

SYSTEMATIC TRANSCRIPTOME ANALYSIS REVEALS DISTINCT COMPETING ENDOGENOUS RNA NETWORK IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ya Zhang, 325387

CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): HIGH-RISK DATA FROM AN IRISH POPULATION.

EHA Library, Carmel Waldron, 325388

INFLUENCE OF INFLAMMATORY CYTOKINES ON S100A PROTEINS EXPRESSION IN CLL PATIENTS

EHA Library, Olivera Mitrovic, 325389

RELEVANCE OF NRF2/KEAP1 AXIS IN CHRONIC LYMPHOCYTIC LEUKEMIA DEVELOPMENT

EHA Library, Ana Ribeiro, 325390

REAL-WORLD APPLICATION OF NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL PRACTICE GUIDELINES IN ONCOLOGY (NCCN GUIDELINES®) FOR CLL/SLL FROM THE INFORMCLL REGISTRY

EHA Library, Jacqueline Barrientos, 325395

SECOND PRIMARY MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Lina Van Der Straten, 325397

ZANUBRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: 34-MONTH FOLLOW-UP RESULTS

EHA Library, Wei Xu, 325399

CONDITIONAL RELATIVE SURVIVAL AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A NATIONWIDE, POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Lina Van Der Straten, 325400

TEN-YEAR FOLLOW-UP OF 415 CLL PATIENTS TREATED WITH FLUDARABINE CYCLOPHOSPHAMIDE-BASED CHEMOIMMUNOTHERAPY IN THE FRONTLINE ARCTIC AND ADMIRE TRIALS, A COMPREHENSIVE ASSESSMENT OF PROGNOSTIC FACTORS

EHA Library, David Allsup, 325404

OUTCOME OF 100 TP53-DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IBRUTINIB. A REAL-LIFE CAMPUS CLL STUDY.

EHA Library, Andrea Visentin, 325405

POTENTIAL CAPABILITIES OF MRNA ROR1 AND MIR-155 FOR MRD ASSESSMENT IN CLL

EHA Library, Marina Stolyar, 325407

SAFETY AND EFFECTIVENESS OF VENETOCLAX IN COMBINATION WITH RITUXIMAB IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY CLL TREATED UNDER REAL-LIFE CONDITIONS – DATA FROM THE OBSERVATIONAL STUDY VERVE

EHA Library, Ingo Schwaner, 325408

COMPARISON OF VENETOCLAX INPATIENT AND OUTPATIENT RAMP-UP STRATEGIES FOR CLL. UK MULTICENTRE RESTROSPECTIVE STUDY

EHA Library, Rocío Figueroa Mora, 325409

TREATMENT OF CLL RELAPSED/REFRACTORY PATIENTS IN COVID-19 PANDEMIC: A REAL-LIFE EXPERIENCE WITH VENETOCLAX-RITUXIMAB COMBINATION IN SOUTHERN ITALY.

EHA Library, stefano molica, 325411

MANAGEMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND ARTERIAL HYPERTENSION WHO ARE ON IBRUTINIB THERAPY.

EHA Library, Elena Emelina, 325413

NEUTROPHIL EXTRACELLULAR TRAPS ARE INCREASED IN CHRONIC MYELOID LEUKEMIA AND ARE DIFFERENTIALLY AFFECTED BY TYROSINE KINASE INHIBITORS

EHA Library, Alona Telerman, 325415

TNF-MEDIATED CML CELL SURVIVAL RESISTS TKI TREATMENT AND THIS CAN BE TARGETED BY IKK2-INHIBITION

EHA Library, Marlena Bütow, 325417

ANALYSIS OF MRNA AND DNA LEVEL OF ATYPICAL BCR-ABL1 TRANSCRIPTS IN CML PATIENTS OUTLINED AN ELIGIBILITY FOR TKI STOPPING

EHA Library, Katerina Machova, 325421

ANALYSIS OF MYELOID MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND THEIR ASSOCIATION WITH ADVERSE EVENTS AND RELAPSE AFTER DISCONTINUATION.

EHA Library, Adrian Segura Díaz, 325422

NEGATIVE PROGNOSTIC IMPACT OF HIGH-RISK ADDITIONAL CYTOGENETIC ABNORMALITIES IN ADDITION TO THE ELTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Camille C.B. Kockerols, 325426

TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE NILOTINIB: RESULTS FROM JALSG N-STOP216

EHA Library, Naoto Takahashi, 325427

TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE DASATINIB: RESULTS FROM JALSG D-STOP216

EHA Library, Yosuke Minami, 325428

COMPARISON OF THE SOKAL AND EUTOS LONG-TERM SURVIVAL SCORES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITORS

EHA Library, Xiaoshuai Zhang, 325429

ASCIMINIB RESPONSES IN PONATINIB-PRETREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Alejandro Luna, 325430

OUTCOMES BEFORE AND AFTER DOSE REDUCTION IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA RECEIVING BOSUTINIB OR IMATINIB

EHA Library, Michael W Deininger, 325431

FRONTLINE TREATMENT APPROACHES FOR CML IN MYELOID BLAST PHASE: A SINGLE-CENTER EXPERIENCE OVER 2 DECADES

EHA Library, Kapil Saxena, 325436

FRENCH REAL–LIFE OBSERVATIONAL STUDY 'TOPASE' EVALUATING SAFETY AND EFFICACY OF PONATINIB CONFIRMS INDUCTION OF DEEP MOLECULAR RESPONSES IN 110 RESISTANT OR INTOLERANT CML PATIENTS

EHA Library, Ali Turhan, 325439

WITHDRAWAL SYNDROME AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Anna Petrova, 325440

FIRST INTERIM RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE

EHA Library, Margarita Gurianova, 325441

A SURVEY OF HEALTHCARE PROFESSIONALS IN THE UNITED KINGDOM TO DESCRIBE CURRENT PATHWAYS AND MANAGEMENT PRACTICES IN CHRONIC MYELOID LEUKAEMIA: THE ADAPT CML SURVEY

EHA Library, Adam Mead, 325442

COMPLEX MODES OF INHERITANCE IN HEREDITARY RED BLOOD CELL DISORDERS: A CASE SERIES STUDY OF 155 PATIENTS

EHA Library, Roberta Russo, 325448

BASELINE CHARACTERISTICS BY AGE OF A GLOBAL COHORT OF PATIENTS DIAGNOSED WITH PYRUVATE KINASE DEFICIENCY – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

EHA Library, Paola Bianchi, 325451

EARLY-ONSET OSTEOPENIA AND OSTEOPOROSIS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Hanny Al-Samkari, 325452

IMPACT OF OLIPUDASE ALFA ENZYME REPLACEMENT THERAPY ON PULMONARY, VISCERAL AND HEMATOLOGIC MANIFESTATIONS OF ACID SPHINGOMYELINASE DEFICIENCY: 1-YEAR RESULTS OF CLINICAL TRIALS IN CHILDREN AND ADULTS

EHA Library, Maurizio Scarpa, 325454

BONE MINERAL DENSITY IS STABLE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY RECEIVING LONG-TERM TREATMENT WITH MITAPIVAT

EHA Library, Hanny Al-Samkari, 325456

SEVERE NEONATAL HAEMOLYTIC ANAEMIA AND SPHEROCYTIC-ELLYPTOCYTOSIS PHENOTYPE DUE TO THE INTERACTION OF THREE NOVEL SPTA1 MUTATIONS

EHA Library, Joan-Lluis Vives-Corrons, 325458

PYRUVATE KINASE DEFICIENCY IN THE RUSSIAN FEDERATION: AN OVERVIEW OF CLINICAL CHARACTERISTICS AND MOLECULAR DEFECTS.

EHA Library, Ekaterina Cherniak, 325459

CLINICAL FEATURES AND TREATMENT RESPONSES IN PEDIATRIC PATIENTS WITH WARM ANTIBODY IMMUNE HEMOLYTIC ANEMIA

EHA Library, Yesim Oymak, 325464

FACIT-FATIGUE SUBSCALE OUTCOMES FROM AN ONGOING PHASE 2, OPEN-LABEL STUDY OF THE PHOSPHATIDYLINOSITOL 3-KINASE DELTA (PI3KΔ) INHIBITOR PARSACLISIB IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

EHA Library, Fabrizio Pane, 325466

USE OF AN NGS PANEL FOR DE DIAGNOSIS OF HEREDITARY HEMOLYTIC ANEMIAS

EHA Library, Irene Zamanillo, 325468

MORTALITY AMONG VETERANS WITH A DIAGNOSIS OF PYRUVATE KINASE DEFICIENCY: A REAL-WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA

EHA Library, Erin Zagadailov, 325470